The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
M Matz(London School of Hygiene & Tropical Medicine), María Paula Curado(AC Camargo Hospital), C. Scandiuzzi, A. Fabowale, I. Kumcher, Eurico Oliveira(London School of Hygiene & Tropical Medicine), Debbie Bradshaw(South African Medical Research Council), S. Bouzbid(University of Oxford), Rajaraman Swaminathan, P.L. Giacciani, Saray Mormeneo Bayo(Netherlands Comprehensive Cancer Organisation), L. Jaïdane(London School of Hygiene & Tropical Medicine), Manar E. Abdel‐Rahman(Qatar University), D.A. Garcilazo(Mthatha General Hospital), Moncef Mokni(Hôpital Farhat Hached), E.A. Laura(London School of Hygiene & Tropical Medicine), Michel P. Coleman(University of London), M.C. Diumenjo, Otto Visser(Netherlands Comprehensive Cancer Organisation), M.A. Green(London School of Hygiene & Tropical Medicine), Zoubida Zaidi, C. Laporte, Florencia Moreno(London School of Hygiene & Tropical Medicine), Daniela Cristina Stefan(SingHealth Duke-NUS Academic Medical Centre), Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Carlos Anselmo Lima(Media Working Group), Nontuthuzelo Somdyala(South African Medical Research Council), B Carballo Quintero, Olufemi J. Ogunbiyi, M.M. El Mistiri, R. Sewpaul-Sungkur, Bertram F. Malle(University of California, Los Angeles), Christel Daniel, María Dolores Chirlaque(Regional Health), Claudia Allemani(London Cancer), S S Manraj(Public Health England), C.D. Melo, S.B. Espinola, R Fita, S.G. Ibañez(Clínica Girona), M.S. González(University of Oxford), M Hamdi-Chérif(London School of Hygiene & Tropical Medicine), G.H. Calabrano, P.C.F. De Souza, E. Bah(London School of Hygiene & Tropical Medicine), W.D. Laspada, S.H. Nortje(Ospedale Civile di Venezia), Martin Gore(Imperial College London), M.F. Lanza
Cited by 159
Related Papers
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
|The Lancet|2008|644
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631